445 related articles for article (PubMed ID: 27909987)
1. Orexin OX
Jacobson LH; Chen S; Mir S; Hoyer D
Curr Top Behav Neurosci; 2017; 33():105-136. PubMed ID: 27909987
[TBL] [Abstract][Full Text] [Related]
2. Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.
Gotter AL; Forman MS; Harrell CM; Stevens J; Svetnik V; Yee KL; Li X; Roecker AJ; Fox SV; Tannenbaum PL; Garson SL; Lepeleire ID; Calder N; Rosen L; Struyk A; Coleman PJ; Herring WJ; Renger JJ; Winrow CJ
Sci Rep; 2016 Jun; 6():27147. PubMed ID: 27256922
[TBL] [Abstract][Full Text] [Related]
3. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
4. Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice.
Kaushik MK; Aritake K; Cherasse Y; Imanishi A; Kanbayashi T; Urade Y; Yanagisawa M
Sleep; 2021 Aug; 44(8):. PubMed ID: 33609365
[TBL] [Abstract][Full Text] [Related]
5. The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia.
Coleman PJ; Gotter AL; Herring WJ; Winrow CJ; Renger JJ
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():509-533. PubMed ID: 27860547
[TBL] [Abstract][Full Text] [Related]
6. Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators.
Gotter AL; Garson SL; Stevens J; Munden RL; Fox SV; Tannenbaum PL; Yao L; Kuduk SD; McDonald T; Uslaner JM; Tye SJ; Coleman PJ; Winrow CJ; Renger JJ
BMC Neurosci; 2014 Sep; 15():109. PubMed ID: 25242351
[TBL] [Abstract][Full Text] [Related]
7. Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism.
Dugovic C; Shelton JE; Yun S; Bonaventure P; Shireman BT; Lovenberg TW
Front Neurosci; 2014; 8():28. PubMed ID: 24592208
[TBL] [Abstract][Full Text] [Related]
8. Distinct effects of IPSU and suvorexant on mouse sleep architecture.
Hoyer D; Dürst T; Fendt M; Jacobson LH; Betschart C; Hintermann S; Behnke D; Cotesta S; Laue G; Ofner S; Legangneux E; Gee CE
Front Neurosci; 2013; 7():235. PubMed ID: 24368893
[TBL] [Abstract][Full Text] [Related]
9. Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice.
Mahoney CE; Mochizuki T; Scammell TE
Sleep; 2020 Jun; 43(6):. PubMed ID: 31830270
[TBL] [Abstract][Full Text] [Related]
10. Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements.
Roecker AJ; Mercer SP; Bergman JM; Gilbert KF; Kuduk SD; Harrell CM; Garson SL; Fox SV; Gotter AL; Tannenbaum PL; Prueksaritanont T; Cabalu TD; Cui D; Lemaire W; Winrow CJ; Renger JJ; Coleman PJ
Bioorg Med Chem Lett; 2015 Nov; 25(21):4992-4999. PubMed ID: 25613676
[TBL] [Abstract][Full Text] [Related]
11. Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders.
Han Y; Yuan K; Zheng Y; Lu L
Neurosci Bull; 2020 Apr; 36(4):432-448. PubMed ID: 31782044
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders.
Muehlan C; Vaillant C; Zenklusen I; Kraehenbuehl S; Dingemanse J
Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1063-1078. PubMed ID: 32901578
[TBL] [Abstract][Full Text] [Related]
13. Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice.
Keenan RJ; Daykin H; Metha J; Cornthwaite-Duncan L; Wright DK; Clarke K; Oberrauch S; Brian M; Stephenson S; Nowell CJ; Allocca G; Barnham KJ; Hoyer D; Jacobson LH
Br J Pharmacol; 2024 Jan; 181(1):87-106. PubMed ID: 37553894
[TBL] [Abstract][Full Text] [Related]
14. Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities.
Andrews SP; Aves SJ; Christopher JA; Nonoo R
Curr Top Med Chem; 2016; 16(29):3438-3469. PubMed ID: 26416477
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomnia.
Betschart C; Hintermann S; Behnke D; Cotesta S; Fendt M; Gee CE; Jacobson LH; Laue G; Ofner S; Chaudhari V; Badiger S; Pandit C; Wagner J; Hoyer D
J Med Chem; 2013 Oct; 56(19):7590-607. PubMed ID: 23964859
[TBL] [Abstract][Full Text] [Related]
16. Discovery and development of orexin receptor antagonists as therapeutics for insomnia.
Winrow CJ; Renger JJ
Br J Pharmacol; 2014 Jan; 171(2):283-93. PubMed ID: 23731216
[TBL] [Abstract][Full Text] [Related]
17. The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold.
Gotter AL; Winrow CJ; Brunner J; Garson SL; Fox SV; Binns J; Harrell CM; Cui D; Yee KL; Stiteler M; Stevens J; Savitz A; Tannenbaum PL; Tye SJ; McDonald T; Yao L; Kuduk SD; Uslaner J; Coleman PJ; Renger JJ
BMC Neurosci; 2013 Aug; 14():90. PubMed ID: 23981345
[TBL] [Abstract][Full Text] [Related]
18. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
[TBL] [Abstract][Full Text] [Related]
19. Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area.
Mavanji V; Perez-Leighton CE; Kotz CM; Billington CJ; Parthasarathy S; Sinton CM; Teske JA
Sleep; 2015 Sep; 38(9):1361-70. PubMed ID: 25845696
[TBL] [Abstract][Full Text] [Related]
20. Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant.
Raheem IT; Breslin MJ; Bruno J; Cabalu TD; Cooke A; Cox CD; Cui D; Garson S; Gotter AL; Fox SV; Harrell CM; Kuduk SD; Lemaire W; Prueksaritanont T; Renger JJ; Stump C; Tannenbaum PL; Williams PD; Winrow CJ; Coleman PJ
Bioorg Med Chem Lett; 2015 Feb; 25(3):444-50. PubMed ID: 25577040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
